Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-19

Clinical Trial Update: Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial [NA]

View source ↗

Summary

This document describes an ongoing randomized trial sponsored by Benha University comparing platelet-rich plasma injections to botulinum toxin injections for re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)
  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Benha University | Conditions: Overactive Bladder Syndrome, Urinary Urge Incontinence | NA | Status: RECRUITING